📖

Nigrostriatal Dopamine Terminals in Parkinson Disease

active
wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-nigrostriatal-terminals-
Related Entities
cell-types-nigrostriatal-terminals-pd-v2
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
44
Outgoing
45
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (83)
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Metabolic Pathway-Targeted Therapy in ALS60%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study60%
related🧫Brainstem Circuit Modulation for PSP60%
related🧫PSP and CBS Biomarker Validation Study60%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model60%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen60%
related🧫Progranulin Replacement Therapy for FTD — Vector Development60%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio60%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen60%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic60%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr60%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers60%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring60%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker60%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT60%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD60%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des60%
related🧫TDP-43 PET Ligand Development for FTD and ALS60%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk60%
related🧫N-of-1 Clinical Trial Design for CBS/PSP60%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen54%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker54%
related🧫N-of-1 Clinical Trial Design for CBS/PSP54%
related🧫Pre-Symptomatic Tau Detection in MAPT Mutation Carriers54%
related🧫Brainstem Circuit Modulation for PSP54%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio54%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic54%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri54%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring54%
related🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design54%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des54%
related🧫TDP-43 PET Ligand Development for FTD and ALS54%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model54%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr54%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study54%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT54%
related🧫Metabolic Pathway-Targeted Therapy in ALS54%
related🧫PSP and CBS Biomarker Validation Study54%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD54%
related🧫Sleep and Respiratory Network Interaction in ALS — Experimen54%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk54%
related🧫Progranulin Replacement Therapy for FTD — Vector Development54%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Senescent Cell Mitochondrial DNA Release40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
mentions🔬What are the most promising therapeutic strategies for targe40%
related🔬What are the mechanisms underlying selective vulnerability o30%

💬 Discussion